Haemonetics Corporation (HAE)

Haemonetics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021	Mar 28, 2020
Cash & Equivalents	178.8	178.8	284.47	259.5	192.31	137.31
Cash & Cash Equivalents	178.8	178.8	284.47	259.5	192.31	137.31
Cash Growth	-37.15%	-37.15%	9.62%	34.94%	40.05%	-18.92%
Receivables	206.56	206.56	179.14	159.38	127.56	165.21
Inventory	317.2	317.2	259.38	293.03	322.61	270.28
Other Current Assets	66.34	66.34	46.74	44.13	51.07	30.85
Total Current Assets	768.9	768.9	769.72	756.03	693.55	603.64
Property, Plant & Equipment	311.36	311.36	310.89	258.48	217.56	253.4
Goodwill and Intangibles	971.2	971.2	742	777.55	831.93	343.76
Other Long-Term Assets	144.13	144.13	112.22	67.67	76.89	66.31
Total Long-Term Assets	1,427	1,427	1,165	1,104	1,126	663.47
Total Assets	2,196	2,196	1,935	1,860	1,820	1,267
Accounts Payable	73.36	73.36	63.93	58.37	50.29	50.73
Current Debt	10.23	10.23	11.78	214.15	17.02	76.98
Other Current Liabilities	216.8	216.8	176.1	169.75	186.19	147.11
Total Current Liabilities	300.38	300.38	251.82	442.27	253.5	274.82
Long-Term Debt	797.56	797.56	754.1	559.44	690.59	305.51
Other Long-Term Liabilities	137.69	137.69	110.91	108.6	144.17	99.67
Total Long-Term Liabilities	935.25	935.25	865.01	668.04	834.76	405.18
Total Liabilities	1,236	1,236	1,117	1,110	1,088	680
Total Debt	807.79	807.79	765.89	773.59	707.61	382.49
Debt Growth	5.47%	5.47%	-1.00%	9.32%	85.00%	9.25%
Retained Earnings	360.46	360.46	253.17	202.39	157.98	78.51
Comprehensive Income	-35.63	-35.63	-30.38	-25.95	-29.55	-45.14
Shareholders' Equity	959.96	959.96	818	749.42	731.67	587.11
Net Cash / Debt	-628.99	-628.99	-481.42	-514.09	-515.3	-245.18
Net Cash Per Share	-12.24	-12.24	-9.36	-10.01	-10.05	-4.73
Working Capital	468.52	468.52	517.91	313.77	440.05	328.82
Book Value Per Share	18.93	18.93	16.11	14.68	14.44	11.58

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).